Course Summary
Expiration Date: 12/01/2027
Angiotensin receptor blockers are one of the most widely used antihypertensives. They are a first-line choice for treating primary hypertension in the general non-black population and for people 18 years of age who have hypertension and chronic kidney disease. The use of angiotensin receptor blockers is well tolerated as monotherapy and as combination therapy with other antihypertensive medications. There is no antidote for ARB poisoning. The recommended treatment is to use standard and supportive care.
Course Format
Homestudy
Course Syllabus
- Introduction
- Mechanism of Action
- Indications, Dosing, and Administration
- Indications
- Dosing of Commonly Used ARBs:
- Hepatic and Renal Impairment: Dosing Adjustments
- Geriatric Patients: Dosing Adjustments
- Clinical Applications
- Hypertension
- Heart Failure
- Diabetic Nephropathy
- Off-Label Uses
- Warnings and Precautions
- Adverse Effects
- Pregnancy and Breastfeeding
- Clinically Relevant Drug-Drug Interactions
- Enhanced Monitoring Recommendations
- Patient Adverse Reaction Reporting
- Toxicity: Clinical Presentation and Management
- Interprofessional Collaboration
- Clinical Pearls
- #1 – Use in Patients with ACE Inhibitor Intolerance:
- #2 – Use of ARBs for Diabetic Cardiovascular Autonomic Neuropathy
- Case Study: Comorbidity in an Elderly Female
- Summary
Authors
Richard Daniels, PharmD, BCPS
Richard “Cole” Daniels earned his Doctor of Pharmacy(PharmD) from the Skaggs School of Pharmacy at the University of Montana in 2018. Throughout pharmacy school he completed a 3-year internship at Community Medical Center in Missoula, Montana in which he gained valuable experience in an acute care setting. Cole currently serves as a psychiatric clinical staff pharmacist at the Montana State Hospital. He has over 11 years of pharmacy experience having worked in several settings including retail, acute care, and inpatient psychiatric care. Cole has a diverse set of interests. However, acute care medicine, infectious disease, pain management, and asthma/COPD are a primary focus of his at the Montana State Hospital. He obtained board certification as a certified pharmacotherapy specialist in the Spring of 2022.
Elisabeth Gordon, BScPharm, RPh
Elisabeth Gordon earned her BSc(Pharm) from the University of British Columbia in 2004. After graduation, she worked in community retail pharmacies on Vancouver Island, before returning to her rural hometown of Salmon Arm. In 2016 and 2017, Elisabeth trained with Pallium Canada and Victoria Hospice to enhance her knowledge of end-of-life-care and palliative services. She is a volunteer medical supervisor for T1DOutreach, a peer support platform for adults living with type 1 diabetes, and a member of a Canadian peer support group for adults living with Birdshot Uveitis. Elisabeth enjoys working in a small, fast-paced rural pharmacy where she brings compassion and empathy to her everyday practice.